James E Besser - Net Worth and Insider Trading
James E Besser Net Worth
The estimated net worth of James E Besser is at least $104,610 dollars as of 2024-05-16. James E Besser is the See Remarks of Processa Pharmaceuticals Inc and owns about 52,665 shares of Processa Pharmaceuticals Inc (PCSA) stock worth over $104,540. James E Besser is also the 10% Owner of Medifirst Solutions Inc and owns about 696,612 shares of Medifirst Solutions Inc (MFST) stock worth over $70. Details can be seen in James E Besser's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James E Besser has not made any transactions after 2021-04-08 and currently still holds the listed stock(s).
Transaction Summary of James E Besser
James E Besser Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James E Besser owns 9 companies in total, including Processa Pharmaceuticals Inc (PCSA) , Minim Inc (MINM) , and SideChannel Inc (SDCH) among others .
Click here to see the complete history of James E Besser’s form 4 insider trades.
Insider Ownership Summary of James E Besser
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PCSA | Processa Pharmaceuticals Inc | 2021-04-08 | 10 percent owner |
MINM | Minim Inc | 2015-09-25 | 10 percent owner |
SDCH | SideChannel Inc | 2018-07-24 | 10 percent owner |
2019-05-01 | 10 percent owner | ||
2018-11-20 | 10 percent owner | ||
2013-11-22 | 10 percent owner | ||
2021-01-15 | 10 percent owner | ||
2022-06-15 | 10 percent owner | ||
2022-06-06 | director & other: Director by Deputization |
James E Besser Latest Holdings Summary
James E Besser currently owns a total of 2 stocks. Among these stocks, James E Besser owns 52,665 shares of Processa Pharmaceuticals Inc (PCSA) as of April 8, 2021, with a value of $104,540 and a weighting of 99.93%. James E Besser also owns 696,612 shares of Medifirst Solutions Inc (MFST) as of May 1, 2019, with a value of $70 and a weighting of 0.07%.
Latest Holdings of James E Besser
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PCSA | Processa Pharmaceuticals Inc | 2021-04-08 | 52,665 | 1.99 | 104,540 |
MFST | Medifirst Solutions Inc | 2019-05-01 | 696,612 | 0.00 | 70 |
Holding Weightings of James E Besser
James E Besser Form 4 Trading Tracker
According to the SEC Form 4 filings, James E Besser has made a total of 4 transactions in Processa Pharmaceuticals Inc (PCSA) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Processa Pharmaceuticals Inc is the sale of 22,389 shares on April 8, 2021, which brought James E Besser around $5 Million.
According to the SEC Form 4 filings, James E Besser has made a total of 0 transactions in Medifirst Solutions Inc (MFST) over the past 5 years. The most-recent trade in Medifirst Solutions Inc is the acquisition of 96,612 shares on May 1, 2019, which cost James E Besser around $6,763.
Insider Trading History of James E Besser
- 1
James E Besser Trading Performance
GuruFocus tracks the stock performance after each of James E Besser's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James E Besser is 8.48%. GuruFocus also compares James E Besser's trading performance to market benchmark return within the same time period. The performance of stocks bought by James E Besser within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James E Besser's insider trading performs compared to the benchmark.
Performance of James E Besser
James E Besser Ownership Network
Ownership Network List of James E Besser
Ownership Network Relation of James E Besser
James E Besser Owned Company Details
What does Processa Pharmaceuticals Inc do?
Who are the key executives at Processa Pharmaceuticals Inc?
James E Besser is the 10 percent owner of Processa Pharmaceuticals Inc. Other key executives at Processa Pharmaceuticals Inc include director & 10 percent owner & President & CEO David Young , Chief Business - Strategy Off Patrick Lin , and Chief Executive Officer George K Ng .
Processa Pharmaceuticals Inc (PCSA) Insider Trades Summary
Over the past 18 months, James E Besser made no insider transaction in Processa Pharmaceuticals Inc (PCSA). Other recent insider transactions involving Processa Pharmaceuticals Inc (PCSA) include a net purchase of 161,000 shares made by David Young , a net purchase of 10,000 shares made by George K Ng , and a net purchase of 8,000 shares made by Justin W Yorke .
In summary, during the past 3 months, insiders sold 0 shares of Processa Pharmaceuticals Inc (PCSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Processa Pharmaceuticals Inc (PCSA) were sold and 69,000 shares were bought by its insiders, resulting in a net purchase of 69,000 shares.
Processa Pharmaceuticals Inc (PCSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Processa Pharmaceuticals Inc Insider Transactions
James E Besser Mailing Address
Above is the net worth, insider trading, and ownership report for James E Besser. You might contact James E Besser via mailing address: 3 West Hill Place, Boston Ma 02114.